ANDA 202206, held by Ph Health. Pramipexole Dihydrochloride.
As of Nov 15, 2026, ANDA 202206 (Pramipexole Dihydrochloride), held by Ph Health, was first approved by FDA on Feb 6, 2014, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 2014 | Original application | Approved | None posted |
| Pramipexole Dihydrochloride0.375MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride0.75MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride1.5MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride2.25MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride3MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride3.75MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Pramipexole Dihydrochloride4.5MG · tablet, extended release;oral | Pramipexole Dihydrochloride | Discontinued |
| Oct 19, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 13Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 16Labeling · Standard review | Approved | None posted |
| Oct 19, 2020 | Supplement 18Labeling · Standard review | Approved | None posted |
| Mar 28, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Mar 28, 2016 | Supplement 10Labeling · Standard review | Approved | None posted |
| Mar 28, 2016 | Supplement 4Labeling · Standard review | Approved | None posted |
| Feb 6, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters